CEDRUS’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$677K Buy
1,158
+10
+0.9% +$5.66K 0.25% 81
2024
Q2
$585K Sell
1,148
-11
-0.9% -$5.39K 0.29% 66
2024
Q1
$573K Sell
1,159
-111
-9% -$56.4K 0.31% 65
2023
Q4
$669K Sell
1,270
-1
-0.1% -$533 0.41% 42
2023
Q3
$641K Sell
1,271
-128
-9% -$63K 0.46% 41
2023
Q2
$672K Sell
1,399
-5
-0.4% -$2.44K 0.47% 38
2023
Q1
$664K Sell
1,404
-88
-6% -$42.5K 0.47% 40
2022
Q4
$791K Sell
1,492
-63
-4% -$33.4K 0.64% 31
2022
Q3
$785K Buy
1,555
+46
+3% +$24.2K 0.74% 29
2022
Q2
$775K Buy
1,509
+136
+10% +$68.3K 0.76% 29
2022
Q1
$700K Sell
1,373
-117
-8% -$56.4K 0.63% 35
2021
Q4
$749K Buy
+1,490
New +$674K 0.72% 35

Other funds holding UNH

CEDRUS's UNH Position: Q3 2024 in Review

CEDRUS increased its UnitedHealth (UNH) stake by 0.87% in Q3 2024, buying an estimated $5.66K and bringing the position to 1,158 shares worth $677K. The position accounts for 0.25% of the portfolio, ranked #81.

CEDRUS first reported a position in UNH in Q4 2021 and has held it in 12 quarters since. The position peaked at $791K in Q4 2022. 3,468 funds tracked by Wall St. Rank hold UNH as of Q3 2024.

  • CEDRUS held 1,158 shares of UnitedHealth worth $677K as of Q3 2024.
  • CEDRUS bought 10 UnitedHealth shares in Q3 2024, an estimated $5.66K.
  • UnitedHealth made up 0.25% of CEDRUS's portfolio in Q3 2024, its #81 holding.
  • CEDRUS first reported a position in UnitedHealth in Q4 2021 and has held it in 12 quarters since.
  • CEDRUS's UnitedHealth position peaked at $791K in Q4 2022.
  • 3,468 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.